NEUROONE MEDICAL TECHNOLOGIES Corp — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
David Rosa (CEO) and Christopher Volker (CFO) certified the June 30, 2026 Form 10-Q on August 13, 2026, attesting that the report contains no material misstatements, that financial statements fairly present the company's condition and operations, and that disclosure controls and internal controls over financial reporting are designed and functioning effectively. No specific operational, financial, or strategic changes are disclosed in these certification exhibits.
Why this rating
Routine Sarbanes-Oxley 302/906 certifications; boilerplate compliance documentation with no material facts, transactions, or operational changes disclosed. Standard periodic filing.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.